BioPharma Dive March 26, 2025
Jonathan Gardner

The Johns Hopkins surgeon will helm the agency as layoffs loom and important decisions on treatments for rare and infectious diseases await.

The U.S. Senate on Tuesday confirmed Johns Hopkins University surgeon Martin Makary to be commissioner of the Food and Drug Administration, giving him authority over an agency that regulates a wide swathe of the U.S. economy that includes food, tobacco, drugs and medical devices.

Three Democrats joined 53 Republicans to confirm Makary in a 56-44 vote. Sen. Bernie Sanders, the senior minority member of the Senate Health, Education, Labor and Pensions Committee, voted no.

HELP Committee Chairman Bill Cassidy, R-La., praised Makary’s confirmation, saying in a statement that his “medical background and strong vision make him more than...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Congress / White House, FDA, Govt Agencies
Related Articles:
Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
HHS plans for workforce reduction may impact FDA operations
Faster Cancer Drug Approvals Tied to Clinical Benefits
Health policy roundup: Senate confirms NIH director, FDA commissioner

Share This Article